
Personalizing Lung Cancer Treatment Reduces Toxicity and Improves Cure Rates
Non–small cell lung cancer (NSCLC) causes approximately 2 million deaths each year worldwide.1 Approximately one-third of patients initially present with locally advanced disease, meaning that the cancer is bulky and/or involves regional lymph nodes …